Countdown to Crunch Time: How Early and Continual Regulatory Engagement Leads to Regulatory and Commercial Success
April 22, 11 am EST
0
days leftAbout this webinar
In the webinar “Countdown to Crunch Time: How Early and Continual Regulatory Engagement Leads to Regulatory and Commercial Success,” industry-leading regulators with extensive experience in both the biopharma and the CRO space engage in a not-to-be-missed, dynamic conversation. Participants will uncover vital strategies for navigating regulatory pathways seamlessly. By avoiding common pitfalls that could jeopardize submission deadlines, attendees will gain invaluable insights into safeguarding project timelines.
Additionally, this webinar will shed light on the often-overlooked advantages of early and continual engagement with regulatory agencies and how proactive collaborative efforts in the early stages can significantly enhance efficiency and mitigate risks. By sharing lessons learned and expert strategies, participants will be well-equipped to streamline their regulatory journey, ensuring overall success.
Key Takeaways:
- Avoid pitfalls that could derail your deadlines
- Discover the hidden benefits of early and continual engagement
- Learn lessons and master strategies to streamline and drive for regulatory success
Date
April 22, 11 am EST
Linda Bowen
M.S, RAC (US, EU, CAN), FRAPS, Business Operations and Integration Lead for Pfizer Oncology Global Regulatory Strategy group
